Total Payments
$2,941
2024 Payments
$919.42
Companies
27
Transactions
109
Medicare Patients
638
Medicare Billing
$68,601
Payment Breakdown by Category
Food & Beverage$2,852 (97.0%)
Education$88.89 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,852 | 107 | 97.0% |
| Education | $88.89 | 2 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $292.85 | 13 | $0 (2024) |
| Boston Scientific Corporation | $282.58 | 4 | $0 (2024) |
| Novo Nordisk Inc | $221.72 | 7 | $0 (2024) |
| SCPHARMACEUTICALS INC. | $211.73 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $202.40 | 7 | $0 (2024) |
| Abbott Laboratories | $168.32 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $141.93 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139.90 | 7 | $0 (2024) |
| ABIOMED | $128.45 | 3 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $127.29 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $919.42 | 42 | SCPHARMACEUTICALS INC. ($173.83) |
| 2023 | $1,241 | 44 | Novo Nordisk Inc ($181.89) |
| 2022 | $780.84 | 23 | Boston Scientific Corporation ($204.05) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: Cardiovascular | ||||||
| 11/19/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Not Applicable | ||||||
| 11/04/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Obesity | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/06/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiology | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: DIABETES | ||||||
| 07/31/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.40 | General |
| 07/30/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 544 | 678 | $218,450 | $58,357 |
| 2022 | 4 | 94 | 104 | $38,155 | $10,244 |
Total Patients
638
Total Services
782
Medicare Billing
$68,601
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 133 | 134 | $97,995 | $21,314 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 109 | $33,470 | $10,354 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $30,535 | $9,264 | 30.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 74 | 75 | $23,530 | $7,744 | 32.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 72 | $12,305 | $4,707 | 38.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 30 | $7,650 | $2,949 | 38.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 121 | 181 | $12,965 | $2,025 | 15.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 36 | 36 | $25,740 | $6,231 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $7,110 | $2,516 | 35.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 19 | $3,135 | $1,119 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 28 | 31 | $2,170 | $378.09 | 17.4% |
About Dr. Sneha Agarwalla, MD
Dr. Sneha Agarwalla, MD is a Cardiovascular Disease healthcare provider based in Bloomfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1801245162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sneha Agarwalla, MD has received a total of $2,941 in payments from pharmaceutical and medical device companies, with $919.42 received in 2024. These payments were reported across 109 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,852).
As a Medicare-enrolled provider, Agarwalla has provided services to 638 Medicare beneficiaries, totaling 782 services with total Medicare billing of $68,601. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Bloomfield, CT
- Active Since 06/08/2016
- Last Updated 07/13/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801245162
Products in Payments
- Repatha (Biological) $292.85
- JARDIANCE (Drug) $261.73
- WATCHMAN Access System (Device) $228.30
- FUROSCIX (Drug) $211.73
- LEQVIO (Drug) $168.87
- CARDIOMEMS (Device) $144.42
- Impella (Device) $128.45
- LifeVest (Device) $127.29
- Arcalyst (Drug) $126.06
- CAMZYOS (Drug) $116.33
- Inpefa (Drug) $96.25
- VYNDAQEL (Drug) $95.53
- XARELTO (Drug) $80.63
- FARXIGA (Drug) $65.54
- Ozempic (Drug) $63.99
- Vascepa (Drug) $55.29
- ELIQUIS (Drug) $52.23
- ONPATTRO (Drug) $42.78
- MULTAQ (Drug) $39.94
- Wegovy (Drug) $39.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bloomfield
Brett Nowlan, Md, MD
Cardiovascular Disease — Payments: $951,843
Cardiovascular Disease $951,843
Ronald Bloom, M.d, M.D
Cardiovascular Disease — Payments: $30,875
Cardiovascular Disease $30,875
Dr. Alan Lapa, M.d, M.D
Cardiovascular Disease — Payments: $28,329
Cardiovascular Disease $28,329
Tracy Patel, M.d, M.D
Cardiovascular Disease — Payments: $13,103
Cardiovascular Disease $13,103
Vincent Romano, M.d, M.D
Cardiovascular Disease — Payments: $11,581
Cardiovascular Disease $11,581
Dr. Catalino Delacruz, M.d, M.D
Cardiovascular Disease — Payments: $10,399
Cardiovascular Disease $10,399